AAAAAA
Results: 101-125/265
Authors:
Platz, EA
Kawachi, I
Rimm, EB
Longcope, C
Stampfer, MJ
Willett, WC
Giovannucci, E
Citation: Ea. Platz et al., Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms, PROSTATE C, 2(5-6), 1999, pp. 285-289
Authors:
Saif, MW
Figg, WD
Hewitt, S
Brosky, K
Reed, E
Dahut, W
Citation: Mw. Saif et al., Malignant ascites as only manifestation of metastatic prostate cancer, PROSTATE C, 2(5-6), 1999, pp. 290-293
Citation: The British Prostate Group Autumn Meeting, 20-21 September 1999, Keble College, Oxford - Abstracts, PROSTATE C, 2(5-6), 1999, pp. 294-299
Authors:
Belldegrun, A
Citation: A. Belldegrun, What's hot in the prostate?, PROSTATE C, 2(4), 1999, pp. 163-165
Authors:
Kirby, R
Scher, H
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 2(4), 1999, pp. 166-166
Authors:
Tyrrell, CJ
Citation: Cj. Tyrrell, Gynaecomastia: aetiology and treatment options, PROSTATE C, 2(4), 1999, pp. 167-171
Authors:
Goktas, S
Ziada, A
Crawford, ED
Citation: S. Goktas et al., Combined androgen blockade for advanced prostatic carcinoma, PROSTATE C, 2(4), 1999, pp. 172-179
Authors:
Maraj, BH
Markham, AF
Citation: Bh. Maraj et Af. Markham, Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene, PROSTATE C, 2(4), 1999, pp. 180-185
Authors:
List, MA
Sinner, M
Chodak, GW
Citation: Ma. List et al., Improving knowledge about prostate cancer: the development of an educational program for African-Americans, PROSTATE C, 2(4), 1999, pp. 186-190
Authors:
Parker, CC
Husband, J
Dearnaley, DP
Citation: Cc. Parker et al., Lymph node staging in clinically localized prostate cancer, PROSTATE C, 2(4), 1999, pp. 191-199
Authors:
Pannek, J
Berges, RR
Sauvageot, J
Lecksell, KL
Epstein, JI
Partin, AW
Citation: J. Pannek et al., Cell turnover in human seminal vesicles and the prostate: an immunohistochemical study, PROSTATE C, 2(4), 1999, pp. 200-203
Authors:
Erbersdobler, A
Graefen, M
Wullbrand, A
Hammerer, P
Henke, RP
Citation: A. Erbersdobler et al., Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality, PROSTATE C, 2(4), 1999, pp. 204-210
Authors:
Tomic, R
Ljungberg, B
Citation: R. Tomic et B. Ljungberg, Effects of hCG stimulation after withdrawal of long-term oestrogen treatment in patients with prostate carcinoma, PROSTATE C, 2(4), 1999, pp. 211-214
Authors:
Kirby, RS
Citation: Rs. Kirby, Proceedings of the symposium: 'Alpha(1) Blockers in BPH Treatment: Towardsthe Next Millennium and Beyond' - Held during the XIVth EAU Congress Stockholm, Sweden April 1999 - Introduction, PROSTATE C, 2, 1999, pp. S1-S1
Authors:
Kirby, RS
Citation: Rs. Kirby, The prostate, men and men's health, PROSTATE C, 2, 1999, pp. S2-S4
Authors:
Andersson, KE
Citation: Ke. Andersson, The pharmacological perspective: role for the sympathetic nervous system in micturition and sexual function, PROSTATE C, 2, 1999, pp. S5-S8
Authors:
Hofner, K
Citation: K. Hofner, alpha(1)-blocker therapy in the nineties: focus on the disease, PROSTATE C, 2, 1999, pp. S9-S15
Authors:
O'Leary, MP
Citation: Mp. O'Leary, alpha(1)-blockade in the nineties: focus on the patient, PROSTATE C, 2, 1999, pp. S16-S20
Authors:
Gomez-Sancha, F
Citation: F. Gomez-sancha, BPH in the next millennium: a glimpse to the future, PROSTATE C, 2, 1999, pp. S21-S25
Authors:
Kirby, R
Brawer, M
Scher, H
Citation: R. Kirby et al., Untitled, PROSTATE C, 2(3), 1999, pp. 109-109
Authors:
Lowe, F
Citation: F. Lowe, Alpha-1-adrenoceptor blockade in the treatment of benign prostatic hyperplasia, PROSTATE C, 2(3), 1999, pp. 110-119
Authors:
Newling, DWW
Citation: Dww. Newling, Clinical trials in prostatic cancer - interpretations and misinterpretations, PROSTATE C, 2(3), 1999, pp. 120-125
Authors:
Costa-Pereira, AP
Cotter, TG
Citation: Ap. Costa-pereira et Tg. Cotter, Molecular and cellular biology of prostate cancer - the role of apoptosis as a target for therapy, PROSTATE C, 2(3), 1999, pp. 126-139
Authors:
Bjartell, A
Siivola, P
Hulkko, S
Pettersson, K
Rundt, K
Lilja, H
Lovgren, T
Citation: A. Bjartell et al., Time-resolved fluorescence imaging (TRFI) far direct immunofluorescence ofPSA and alpha-1-antichymotrypsin in prostatic tissue sections, PROSTATE C, 2(3), 1999, pp. 140-147
Authors:
Martenson, AC
de la Rosette, JJMCH
Citation: Ac. Martenson et Jjmch. De La Rosette, Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: results of an evolving technology, PROSTATE C, 2(3), 1999, pp. 148-154